Rob Brierley(@Rob__Brierley) 's Twitter Profileg
Rob Brierley

@Rob__Brierley

Editor-in-Chief The Lancet Gastroenterology & Hepatology @lancetgastrohep #gastroenterology #hepatology #oncology. Views my own.

ID:1956282006

calendar_today12-10-2013 10:16:07

976 Tweets

987 Followers

1,0K Following

The Lancet Gastroenterology & Hepatology(@LancetGastroHep) 's Twitter Profile Photo

New podcast online🎙️

We spoke to Nuru Noor about the genesis and findings of the PROFILE RCT (PROFILE Crohn's Trial), which found a benefit of very early treatment with combined anti-TNF & immunomodulator in disease

Listen🔊buzzsprout.com/1728646/150235…

📜thelancet.com/journals/langa…

account_circle
The Lancet Gastroenterology & Hepatology(@LancetGastroHep) 's Twitter Profile Photo

Our June issue is out now at thelancet.com/gastrohep!

Content: management of IBS, loss of response to anti-TNF in Crohn’s, HCC surveillance in Africa, the environmental impact of gastroenterology, liver transplant for ACLF, MASLD, viral hepatitis + more

Our June issue is out now at thelancet.com/gastrohep! Content: management of IBS, loss of response to anti-TNF in Crohn’s, HCC surveillance in Africa, the environmental impact of gastroenterology, liver transplant for ACLF, MASLD, viral hepatitis + more #GITwitter #LiverTwitter
account_circle
Rob Brierley(@Rob__Brierley) 's Twitter Profile Photo

Results from four phase 1 & 2 trials of ifasutenizol, a novel dual-targeted antibacterial in healthy participants and patients with Helicobacter pylori infection identifies potential new triple regimen for infection

thelancet.com/journals/lanin…

The Lancet Infectious Diseases

account_circle
Rob Brierley(@Rob__Brierley) 's Twitter Profile Photo

Recently in The Lancet Gastroenterology & Hepatology: head-to-head comparisons of diets and medical therapy for IBS + a new drug for Alagille syndrome

A summary 👉linkedin.com/posts/rob-brie…

account_circle
Rob Brierley(@Rob__Brierley) 's Twitter Profile Photo

Rare & severe AEs in children w/ inflammatory bowel disease

Data from PIBD-SETQuality Safety Registry

Incidence per 10 000 p-y:
👉VTEs 5·50 (95% CI 4·25–6·97)
👉Renal failure 3·75 (2·74–4·99)
👉Opportunistic infection 3·67 (2·67–4·89)
👉Cancer 2·88 (2·01–3·98)

Rare & severe AEs in children w/ inflammatory bowel disease Data from PIBD-SETQuality Safety Registry Incidence per 10 000 p-y: 👉VTEs 5·50 (95% CI 4·25–6·97) 👉Renal failure 3·75 (2·74–4·99) 👉Opportunistic infection 3·67 (2·67–4·89) 👉Cancer 2·88 (2·01–3·98) #GITwitter #IBD
account_circle
Rob Brierley(@Rob__Brierley) 's Twitter Profile Photo

New The Lancet Reg Health-Europe - major disparities in use of gFOBT, FIT, and colonoscopy for colorectal cancer screening across European countries

thelancet.com/journals/lanep…

OncoAlert

account_circle
Rob Brierley(@Rob__Brierley) 's Twitter Profile Photo

New The Lancet Digital Health - AI-assisted capsule endoscopy reading in suspected small bowel bleeding

Diagnostic yield for P1 + P2 lesions in AI-assisted reading non-inferior (& superior) to standard reading (98/133 lesions vs 82/133)

thelancet.com/journals/landi…

New @LancetDigitalH - AI-assisted capsule endoscopy reading in suspected small bowel bleeding Diagnostic yield for P1 + P2 lesions in AI-assisted reading non-inferior (& superior) to standard reading (98/133 lesions vs 82/133) thelancet.com/journals/landi… #GITwitter
account_circle
Rob Brierley(@Rob__Brierley) 's Twitter Profile Photo

New eClinicalMedicine – The Lancet Discovery Science - Safety & feasibility of chemotherapy followed by liver transplantation for unresectable colorectal liver metastases: insights from the TransMet RCT

thelancet.com/journals/eclin…

OncoAlert

account_circle
The Lancet Gastroenterology & Hepatology(@LancetGastroHep) 's Twitter Profile Photo

New podcast online🎙️

Can we simplify treatment eligibility in sub-Saharan African settings?

We spoke to Yusuke Shimakawa about work on a new treatment eligibility score to decentralise care
🔊buzzsprout.com/1728646/149318…
📜thelancet.com/journals/langa…

account_circle
Rob Brierley(@Rob__Brierley) 's Twitter Profile Photo

PRODIGE 60: immunotherapy for anal squamous cell carcinoma?

👉12 m PFS w/ atezolizumab + mDCF 45%; 43% w/ mDCF alone; did not meet 1ry endpoint

👉Toxicity increased w/ atezolizumab

👉But... suggestion of benefit in pts w/ PD-L1 CPS 5+?

OncoAlert

account_circle
The Lancet Gastroenterology & Hepatology(@LancetGastroHep) 's Twitter Profile Photo

Today marks .

Raising awareness of liver health is crucial—90% of cases of liver disease are preventable, the major causes being alcohol, viral hepatitis, and obesity

Today marks #WorldLiverDay. Raising awareness of liver health is crucial—90% of cases of liver disease are preventable, the major causes being alcohol, viral hepatitis, and obesity #LiverTwitter
account_circle